FDA Clears NeuroStar’s TMS Therapy for Adolescents with Major Depressive Disorder
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced this week that the U.S. Food and Drug Administration (FDA) has granted clearance for its NeuroStar Advanced Therapy system as an adjunct …
FDA Clears NeuroStar’s TMS Therapy for Adolescents with Major Depressive Disorder Read More